Advertisement

Rauschdrogen pp 373-510 | Cite as

Stimulantia

  • Thomas Geschwinde

Zusammenfassung

Vorbemerkung: Die Zusammenfassung verschiedener Wirkstoffe unter diesem, von lat. stimulus (Stachel, Antrieb, Reiz) abgeleiteten Begriff stellt auf die charakteristische anregende und leistungssteigernde Wirkungskomponente dieser Gruppe von Rauschdrogen ab (engl. CNS Stimulants). Synonym wird der ältere, von Lewin geprägte, heute weniger gebräuchliche Begriff „Excitantia“ verwandt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Amin M et al. (1990) Acute myocordial infarction and chest pain syndrome after cocaine use. Am J Cardiol 66: 1434–1437CrossRefGoogle Scholar
  2. Andrews P (1997) Cocaethylene toxicity. J Addict Dis 16: 75–84CrossRefGoogle Scholar
  3. Asghar K, De Souza E (eds)(1989) Pharmacology and toxicology of amphetamine and related designer drugs. NIDA Res Monogr 94Google Scholar
  4. Axt KJ, Molliver ME (1991) Immunocytochemical evidence for methamphetamine-induced serotonergic exon loss in the rat brain. Synapse 9: 302–313CrossRefGoogle Scholar
  5. Bachmann P (1976) Das hyperkinetische Syndrom im Kindesalter. Huber, BernGoogle Scholar
  6. Baumgartner WA, Black CT, Jones PF, Bland WH (1982) Radioimmunassay of cocaine in hair, concise communication. J Nucl Med 23: 790–792Google Scholar
  7. Bailey DN (1996) Cocaine and cocaethylene binding to human tissues: A preliminary study. Ther Drug Monit 18: 280–283CrossRefGoogle Scholar
  8. Bell DS (1973) The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29: 34–40CrossRefGoogle Scholar
  9. Beck NE, Hale JE (1993) Cocaine “body-packers”. Brit J Surg 80: 1513–1516CrossRefGoogle Scholar
  10. Beck O, Kraft M, Moeller M, Smith BL et al. (2000) Frontline immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens. Am Clin Biochem 37 (Ptz): 199–204CrossRefGoogle Scholar
  11. Beil H, Trojan A (1974) Zur Problematik des Amphetaminil (AN 1)-Missbrauchs. Mmw 116 /48: 2121–2123Google Scholar
  12. Bejerot N (1970) A comparison of the effects of cocaine and synthetic central stimulants. Br J Addict 65: 35–37CrossRefGoogle Scholar
  13. Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111: 701–707CrossRefGoogle Scholar
  14. Benchimol A, Bartrail H, Dresser KB (1978) Accelerated ventricular rhythm and cocaine abuse. Ann Intern Med 88: 519–521Google Scholar
  15. Bettinger J (1980) Cocain intoxication, massive oral overdose. Ann Emerg Med 10: 429–433CrossRefGoogle Scholar
  16. Birkholz M, Kropp S, Bleich S et al. (1997) Exkorporation von Betäubungsmitteln. Kriminalistik 4: 277–283Google Scholar
  17. Birnbach DJ, Stein DJ, Thomas K (1993) Instant recognition of the cocaine abusing parturient. Anesthesiol 79: A987Google Scholar
  18. Blejer-Prieto H (1965) Coca leaf and cocaine addiction–some historical notes. Can Med Assoc J 93: 700–704Google Scholar
  19. Bogusz MJ, Schmidt G (1991) Cocain-Missbrauch–Neue Bedrohung mit der alten Substanz. Zbl Rechtsmed 35: 783–793Google Scholar
  20. Bogusz MJ, Kala M, Maier RD (1997) Determination of phenylisothiocyanate derivates of amphetamine and its analogues in biological fluids by HPLC-APCI-MS or DAD. J Anal Toxicol 21: 59–69Google Scholar
  21. Briellmann TA, Dussy FE, Schwerzmann T, Dittmann V (2001) Cocain und Heroin auf Banknoten. Kriminalistik 2: 113–116Google Scholar
  22. Bruns 0 (1941) Pervitin–Pharmakologie und Klinik. Fortschr Ther 17: 37–44, 90–100Google Scholar
  23. Brzezinski MR, Spink BJ, Dean RA et al. (1997) Human liver carboxylesterase hCE-1: binding specifity for cocaine, heroin, and their metabolites and analogs. Drug Metab Dispos 25: 1089–1096Google Scholar
  24. Bundeskriminalamt (Hrsg.) (1981) Kokain-Informationsschrift. WiesbadenGoogle Scholar
  25. Bunn WH, Giannini AJ (1992) Cardiovascular complications of cocaine abuse. Am Fam Physician 45: 769–773Google Scholar
  26. Caldwell J et al. (1974) The biochemical pharmacology of drug abuse. I. Amphetamine, cocaine and LSD. Clin Pharmacol Ther 16: 625–633Google Scholar
  27. Chambers CD, Taylor WJR, Moffett AD (1972) The incidence of cocaine abuse among methadone maintenance patients. Int J Addict 7: 427–441Google Scholar
  28. Cleckner PJ (1976) Blowing some lines: Intracultural variation among Miami cocaine users. J Psychedelic Drugs 8: 37–42CrossRefGoogle Scholar
  29. Cohen H (1972) The amphetamine manifesto. Olympia Press, New YorkGoogle Scholar
  30. Cohen SV (1976) Influence of cocaine on sexuality. Med Aspects Hum Sex 10: 149–152Google Scholar
  31. Colpaert FC et al. (1978) Neuroleptic interference with the cocaine cue: Internal stimulus control of behavior and psychosis. Psychopharmacology (Berlin) 58: 257CrossRefGoogle Scholar
  32. Cone EJ (1995) Pharmacokinetics and pharmacodynamic of cocaine. J Anal Toxicol 19: 459–478Google Scholar
  33. Cone EJ, Weddington WW (1989) Prolonged occurence of cocaine in human saliva and urine after chronic abuse. J Anal Toxicol 13: 65–68Google Scholar
  34. Cone EJ, Oyler J, Darwin WD (1997) Cocaine Disposition in Saliva Following Intravenous, Intranasal and Smoked Administration. J Anal Toxicol 21: 465–475Google Scholar
  35. Connell PH (1958) Amphetamine psychosis. Chapman Hall, LondonGoogle Scholar
  36. Cooper H, Ellinwood EH (1981) Cocain und Cocainismus. Dtsch Ärztebl 19: 173–179Google Scholar
  37. Cregler LL, Mark H (1986) Special report: Medical complications of cocaine abuse. N Engl J Med 315: 1495–1500Google Scholar
  38. Crowley A (1973) Cocaine. Level, San FranciscoGoogle Scholar
  39. Daras M, Tuchmann AJ, Koppel BS et al. (1994) Neurovascular complications of cocaine. Acta Neurol Scand 90: 124–129CrossRefGoogle Scholar
  40. Darke S, Hall W (1995) Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 39: 231–235CrossRefGoogle Scholar
  41. Daube H (1942) Pervitinpsychosen. Nervenarzt 15: 20–25Google Scholar
  42. Dyke C van, Jatlow P, Ungerer J, Barash PG (1978) Oral cocaine: Plasma concentrations and central effects. Science 200: 211–213Google Scholar
  43. Dyke C van et al. (1979) Cocaine and lidocaine have similar psychological effects after intranasal application. Life Sci 24: 271–274CrossRefGoogle Scholar
  44. Ellinwood EH Jr, Kilbey MM (eds)(1977) Cocaine and other stimulants. Plenum, New YorkGoogle Scholar
  45. Epstein PN et al. (1978) Changes in effects of cocaine during chronic treatment. Res Commun Chem Pathol Pharmacol 22: 93–105Google Scholar
  46. Erhardt E (1993) Wie gefährlich ist Kokain ? Kriminalistik 7: 447–452Google Scholar
  47. Favre M, de la Torre R, Gonzalez ML et al. (1997) Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther 283: 164–176Google Scholar
  48. Fisch F, Wilson DC (1969) Excretion of cocaine and its metabolits in man. J Pharm Pharmacol 21: 135SGoogle Scholar
  49. Fleurentin J, Pelt JM (1982) Repertory of drugs and medical plants of Yemen. J Etnopharmacol 6: 85–108CrossRefGoogle Scholar
  50. Fodor G (1965) New methods and recent developments of ephedrine, pyrrolizidine, granatane and tropan alkaloids. Recent Dev Chem Nat Carbon Compounds 1: 15–20Google Scholar
  51. Freisleder A, Bautz W, Schmidt V (1988) Body Packing. Wertigkeit moderner bildgebender Verfahren zum Nachweis inkorporierter Transportmedien. Arch Kriminol 182: 143153Google Scholar
  52. Freyer E (1997) Kokain, Ecstasy und verwandte Designerdrogen. Wirkungsweise, Überdosierung, Therapeutische Notfallmaßnahmen. Johann Ambrosius Barth, Heidelberg LeipzigGoogle Scholar
  53. Galambos E, Pfeifer AK, György L, Molnar D (1967) Study of the excitation induced by amphetamine, cocaine and alpha-methyltryptamine. Psychopharmacologia 11: 122–129CrossRefGoogle Scholar
  54. Gawin FH (1991) Cocaine Addiction: Psychology and Neurophysiology. Science 251: 1580–1586CrossRefGoogle Scholar
  55. Gay GR (1982) Clinical management of acute and chronic cocaine poisoning. Am Emerg Med 11: 562–572CrossRefGoogle Scholar
  56. Gay GR, Sheppard CW, Inaba DS, Newmeyer JA (1973 a) Cocaine in perspective: “Gift from the Sun God” to “The Rich Man’s Drug”. Drug Forum 2: 409–430Google Scholar
  57. Gay GR, Sheppard CW, Inaba DS, Newmeyer JA ( 1973 b) An old girl: Flyin’ slow, dyin’ slow, blindes by snow: Cocaine in perspective. Int J Addict 8: 1027–1042Google Scholar
  58. Goeders NE, Smith JE (1983) Cortical dopaminergic involvement in cocaine reinforcement. Science 221: 773–775CrossRefGoogle Scholar
  59. Gorodetzky CW (1970) Marihuana, LSD, Amphetamines. Drug Depend 5: 61–66Google Scholar
  60. Grabowsky J (ed)(1984) Cocaine: Pharmacology, effects and treatment of abuse. NIDA Res Monogr, Rockville/MDGoogle Scholar
  61. Grasshof H (1962) Zusammenhänge zwischen Konstitution und Wirksamkeit bei Lokalanästhetica. Fortschr Arzneimittelforsch 4: 353–357Google Scholar
  62. Grinspoon L, Bakalar JB (1976) Cocaine: A drug and its social evolution. Basic Books, New YorkGoogle Scholar
  63. Grinspoon L, Bakalar JB (1977) A kick from cocaine. A review of research on the drug’s effects physical, social, and psychosocial. Psychol Today 3: 41–42, 78Google Scholar
  64. Gundlach H, Metraux (1979) Freund, Kokain, Koller und Schleich. Psyche 33:434–451 Halbach H (1981) Amphetamine. Dtsch Ärztebl 78 /50: 2398–2402Google Scholar
  65. Halikas JA, Crosby RD, Pearson VL et al. (1997) A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clin Pharmacol Ther 62: 89–105CrossRefGoogle Scholar
  66. Hanna JM (1974) Coca leaf use in southern Peru: Some biosocial aspects. Am Anthropol 76: 281–296CrossRefGoogle Scholar
  67. Hanna JM, Hornick CA (1977) Use of coca leaf in southern Peru: adoption or addiction. Bull Narc 29: 63–74Google Scholar
  68. Harkey MR, Henderson GL, Zhou C (1991) Simultaneous Quantitation of Cocain and it’s Major Metabolits in Human Hair by Gaschromatography/Chemical Ionisation Mass Spectrometry. J Anal Toxicol 15: 260–264Google Scholar
  69. Hasse HE, Schönhofer PS, Waldmann H (1973) Die Bedeutung weckaminartiger Substanzen in der Psychodynamik des Drogenkonsums bei Jugendlichen. Dtsch Med Wochenschr 98: 295–301CrossRefGoogle Scholar
  70. Hearn WL, Rose S, Wagner J et al. (1991) Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 39: 531–533CrossRefGoogle Scholar
  71. Heinemann A, Lockermann U, Iwersen S, Puschel K, Schmoldt A (1997) Cocain–Nur eine Modedroge ? Kriminalistik 8–9: 591–595Google Scholar
  72. Hirsch C (1982) Die Stellung des Kokains in der Lokalanästhesie einst und jetzt. Schmerz 1: 105–113Google Scholar
  73. Hoffmann K-D (1998) Kokain–“Schnee” aus den Anden. Kriminalistik 11: 702–705Google Scholar
  74. Hollister LE, Gillespie HK (1970) Marihuana, ethanol and dextroamphetamine–mood and mental function alteration. Arch Clin Psychiatry 23: 199–204CrossRefGoogle Scholar
  75. Holmann RB (1994) Biological effects of central nervous system stimulants. Addiction 89: 1435–1441CrossRefGoogle Scholar
  76. Iffland R (1982) Fenetyllin-und Amphetaminspiegel im Urin nach Einnahme von Capta-gon. Arch Kriminol 169: 81–88Google Scholar
  77. Isner JM, Chokski SK (1991) Cardiovascular complications of cocaine. Curr Probt Cardiol 45: 93–121Google Scholar
  78. Jain NC, Chinn DM, Sneath TC, Budd RD (1977) Simultaneous gas chromatographic determination of cocaine, methadone, methaqualone, phencyclidine, and propoxyphene. J Anal Toxicol 1: 192–194Google Scholar
  79. Javaid JL, Dekirmenjan H, Davis JM, Schuster CR (1978) Determination of cocaine in human urine, plasma and red blood cells by gasliquid chromatography. J Chromatogr 152: 105–113CrossRefGoogle Scholar
  80. Javaid JL, Fischman MW, Schuster CR et al. (1978) Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Sciene 202: 227–228Google Scholar
  81. Jeri FR (1979) Further experience with the syndromes produced by coca paste. Bull Narc 15: 1–8Google Scholar
  82. Jeri FR, Sanchez CC, Del Pozo T, Fernandez M (1978 a) The syndrome of coca paste. J Psychedelic Drugs 10: 361–370Google Scholar
  83. Jeri FR, Sanchez CC, Del Pozo T, Fernandez M (1978 b) Further experience with the syndromes produced by coca paste smoking. Bull Narc 30: 1–11Google Scholar
  84. Jindal SP, Lutz T, Vestergaard P (1978) Mass spectrometic determination of cocaine and its biologically active metabolite, norcocaine, in human urine. Biomed Mass Spectrom 5: 658–663CrossRefGoogle Scholar
  85. Joachim H. Hochreuthér J (1977) Untersuchungen über den Kombinationseffekt von Alkohol - Fenetyllin ( Captagon) auf einige Reflexmechanismen des Menschen. Blutalkohol 14: 25–46Google Scholar
  86. John H, Schoenberger R, Renner N, Ritz R (1992) Cocain-Intoxikation durch Drogentransport im Gastrointestinaltrakt (Body-Packer-Syndrom). Dtsch Med Wochenschr 117/51–52: 1952–1955Google Scholar
  87. Jordan SE, Lasslo A, Livingston HL, Alperin H (1958) Comparative pharmacology of co- caine and the diethylamide derivate of cocaine. Arch Int Pharmacodyn 4: 452–473Google Scholar
  88. Kalix P (1988) Khat–ein pflanzliches Amphetamin. Dtsch Apoth Z 128: 2150–2153Google Scholar
  89. Kalix P (1992) Cathinone, a Natural Amphetamine. Pharmacol Toxicol 70: 77–82CrossRefGoogle Scholar
  90. Kalix P, Brenneisen R, Koelbing U et al. (1991) Khat, eine pflanzliche Droge mit Amphetaminwirkungen. Schweiz Med Wochenschr 121: 1561–1466Google Scholar
  91. Kalus F, Kucher J, Zutt J (1950) Über die psychotischen Bilder bei chronischem Pervitinmissbrauch. Psychiatr Neurol Med Psychol 2: 109–116, 138–144Google Scholar
  92. Karch SB, Billingham BE (1988) The pathology and etiology of cocaineinduced heart disease. Arch Pathol Lab Med 112: 225–230Google Scholar
  93. Katzung W (1991) Drogen: Information in Übersichten V. Abhängigkeit vom Cocain-Typ–Leitdroge Cocain. Medizin aktuell 17: 400–403Google Scholar
  94. Kauert G, Röhrich J, Schmidt K (1995) Bestimmung von Amphetamin. Toxichem Krim-tech 62: 14–20Google Scholar
  95. Kellner E (1960) Preludinsucht und Preludinpsychose. Ther GGW 99 524–530Google Scholar
  96. Keup W (1990) Kokainmissbrauch in der Bundesrepublik Deutschland. BKA Forschungsreihe, Bundeskriminalamt WiesbadenGoogle Scholar
  97. Kilbey MM, Breslau N, Audreski P (1992) Cocaine use and dependence in young adults: associated psychiatric disorders and personality traits. Drug Alcohol Depend 29: 283290Google Scholar
  98. Kogan MJ, Vereby KG, Depace AC et al. (1977) Quantitative determination of benzoylecgonine and cocaine in human biofluids by gasliquid chromatography. Anal Chem 49: 1965–1969CrossRefGoogle Scholar
  99. Körner HH (1989) Doping: Der Drogenmissbrauch im Sport und Stall. Zrp 11: 418–422Google Scholar
  100. Kosten TR, Kleber HD, Morgan C (1989) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44: 887–892CrossRefGoogle Scholar
  101. Kosten TR, Silverman DG, Fleming J et al. (1992) Intravenous Cocaine challenges during naltrexone maintenance: a preliminary study. Biol Psychiatr 32: 543–548CrossRefGoogle Scholar
  102. Kowalewski H (1990) Body-Packer-Syndrom. Rauschgiftschmuggel im menschlichen Körper–Diskussion aus juristischer und medizinischer Sicht an Hand eigener Fälle. Fortschr Med 108 /24: 467–469Google Scholar
  103. Kozel/Adams (eds) (1985) Cocaine Use in America. NIDA Res Monogr Series 61, Rockville/MDGoogle Scholar
  104. Kramer E (1941) Die Pervitingefahr. Mmw 16: 419–427Google Scholar
  105. Krause K-H, Krause J, Trott G-H (1998) Das hyperkinetische Syndrom (Aufmerksamkeits- defizit-/Hyperaktivitätsstörungen) des Erwachsenenalters. Nervenarzt 69 /7: 543–556CrossRefGoogle Scholar
  106. Kuhn KL, Halikas JA, Kemp KD (1989) Carbamazepine treatment of cocaine dependence in methadone maintenance patients with dual opiate-cocaine addiction. NIDA Res Monogr 95: 316–317Google Scholar
  107. Ladewig D, Battegay R, Labhardt F (1969) Stimulantiensucht und -psychosen. Dtsch Med Wochenschr 94: 101–107CrossRefGoogle Scholar
  108. Lange RA et al. (1989) Cocaine induced coronary artery vasoconstriction. N Eng J Med 321: 1557–1562CrossRefGoogle Scholar
  109. Laudry MJ (1992) An overview of cocaethylene, an alcohol-derived, psychoactive, cocaine metabolite. J Psychoactive Drugs 24: 273–276CrossRefGoogle Scholar
  110. Lemmer B (1982) Benzodiazepine und Appetitzügler–Gebrauch und Missbrauch. Med Monatsschr Pharm 4: 225–233Google Scholar
  111. Linck J (1987) Doping und staatliches Recht. Njw 41: 2545–2548Google Scholar
  112. Logan BK, Peterson KL (1994) The origin and significance of ecgonine methyl ester in blood sampl. J Anal Toxicol 18: 124–125Google Scholar
  113. Lundberg GD, Garriott JC, Reynolds PC, Cravey RH (1977) Cocaine-related death. J Forsensic Sci 22: 402–408Google Scholar
  114. Marc B, Brand FJ, Aelion MJ et al. (1990) The cocaine body-packer Syndrome: evaluation of a method of contrast study of the bowel. J Forensic Sci 35 /2: 345–355Google Scholar
  115. Martin RT (1970) The role of coca in the history, religion, and medicine of South American Indians. Econ Bot 24 /4: 422–438CrossRefGoogle Scholar
  116. Marzute PM, Tardiff K, Smyth D et al. (1992) Cocaine Use, Risk Taking and Fatal Russian Roulette. Jama 267 /19: 2635–2637CrossRefGoogle Scholar
  117. Megges G (1983) Massive psychische Abhängigkeit…, Cocain–Cocaismus, Cocainismus. Kriminalistik 2: 62–69Google Scholar
  118. Megges G (1986) “Speed” - Zur Suchtgefährlichkeit der Amphetamine. Kriminalistik 5:224Google Scholar
  119. Minister für Arbeit, Gesundheit und Soziales des Landes NordrheinWestfalen (Hrsg.) (1981) Cocain heute. Dokumentation des IDIS. Verlag für Dokumentation und Information über Sozialmedizin und öffentliches Gesundheitswesen, Bielefeld.Google Scholar
  120. Mittleman RE, Wetly CV (1987) Cocaine and Sudden “Natural” Death. J Forensic Sci 32 /1: 11–19Google Scholar
  121. Mittleman RE, Wetly CV (1991) The Pathology of Cocaine Abuse. Advances in Pathology and Laboratory Medicine. Mosby-Year Book, Inc 37–73Google Scholar
  122. Möller MR, Bregel D, Hartung M, Warth S (1995) Quantitative Bestimmung von Cocain und Benzoylcocain aus Serum mittels Festphasenextraktion. Toxichem Krimtech 62: 28–30Google Scholar
  123. Murphy HBM, Rios O, Negrete JC (1969) The effects of abstinence and of retraining an the chewer of coca leaf. Bull Narc 21: 41–47Google Scholar
  124. Mortimer WG (1974) History of coca. “The divine plant” of the Incas. And/Or Press, San FranciscoGoogle Scholar
  125. Mule SJ (ed)(1976) Cocaine. Chemical, biological, clinical, social and treatment aspects. CRC Press, Cleveland/OHGoogle Scholar
  126. Nichols GR, Davis GJ (1992) Body packing with a twist–death of a sales man. Am J Forens Med Pathol 13: 142–145CrossRefGoogle Scholar
  127. Nieforth KS (1971) Psychotomimetic phenethylamine. J Pharm Sci 60: 655–659CrossRefGoogle Scholar
  128. Nieschulz O (1969) Kokaismus und Kokainismus. Mmw 44: 2276–2284Google Scholar
  129. Nieschulz O (1971) Psychopharmakologische Untersuchungen über Cocain und Ecgonin. Ein Beitrag zum Problem des Cocaismus und Cocainismus. Arzneimittelforsch 21: 275–284Google Scholar
  130. Nieschulz 0, Schmersahl P (1969) Untersuchungen über die Bedeutung des Kalkzusatzes beim Kauen von Coca-Blättern. Planta Med 17: 178–183CrossRefGoogle Scholar
  131. Nobel H (1985) Teufelsdroge Nr. 2 auf dem Vormarsch–Kokain: Schmuggel, Preise, Anwendungsformen. Kriminalistik 3: 130–149Google Scholar
  132. Nossoll M, Teuchert-Noodt G, Dawirs RR (1997) A single dosis of methamphetamine in neonatal gerbils affects adult prefrontal GABA innervation. Eur J Pharmacol 340: 3–5Google Scholar
  133. Pallenbach E (1996) Die Männer mit der dicken Backe. Khat im Jemen. Dtsch Apothek Z 136: 3399–3410Google Scholar
  134. Panse F, Klages W (1964) Klinisch-psychopathologische Beobachtungen bei chronischem Missbrauch von Ephedrin und verwandten Substanzen. Arch Psychiatr Nervenkr 206: 69–95CrossRefGoogle Scholar
  135. Philipps J, Wynne RD (1980) Cocaine. Avon, New YorkGoogle Scholar
  136. Pickering H, Stimson GV (1994) Prevalence and demographic factors of stimulant use. Addiction 89: 1385–1389CrossRefGoogle Scholar
  137. Post RM (1975) Cocaine psychosis: A continuum model. Am J Psychiatry 132: 225–231Google Scholar
  138. Post RM, Kotin J, Goodwin FK (1974) The effects of cocaine on depressed patients. Am J Psychiatry 131: 511–517Google Scholar
  139. Post RM, Kopanda RT (1976) Cocaine, kindling, and psychosis. Am J Psychiatry 133: 627634Google Scholar
  140. Prokop H (1968) Halluzinose bei Ephedrinsucht. Nervenarzt 39: 71–75Google Scholar
  141. Prokop H (1969) Über Fälle mit Ephedrin-und Preludinsucht. Wien Klin Wochenschr 81: 269–271Google Scholar
  142. Puschel K, Schulz F, Iwersen S, Schmoldt A (1995) Tod nach Verschlucken von Rauschgift. Kriminalistik 5: 355–358Google Scholar
  143. Rafla FK, Epstein RL (1979) Identification of cocaine and its metabolits in human urine in the presence of ethyl alcohol. J Anal Toxicol 3: 59–63Google Scholar
  144. Resnick RB, Kestenbaum RS, Schwarz LK (1976) Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes. Psychopharmacol Bull 12: 44–45Google Scholar
  145. Rezkalla SH, Hale S, Kloner RA (1990) Cocaine induced heart diseases. Am Heart J 120 /6: 1403–1408CrossRefGoogle Scholar
  146. Ritz MG, Kuhar MJ (1989) Relationship between a self administration of amphetamine and monoamine receptors: comparison with cocaine. J Pharmacol Exp Ther 248: 1010–1017Google Scholar
  147. Röhrich J, Schmidt K, Bratzke H (1995) Nachweis von Amphetamin-Derivaten bei chemisch-toxikologischen Untersuchungen über den Zeitraum 1987–1993 im Großraum Frankfurt. Blutalkohol 32: 42–29Google Scholar
  148. Sahihi A (1990) Designer-Drogen: Crack, die effektvollste aller Zerstörungen. Suchtreport 4 /6: 42–47Google Scholar
  149. Sano J, Nagasaka (1956) Über chronische Weckaminsucht in Japan. Fortschr Neurol Psychiatr 24: 291–394Google Scholar
  150. Sauer W, Freislederer A, Graw W, Schmidt V (1988) Sonografie bei intrakorporalem Drogenschmuggel. Dtsch Med Wochenschr 114: 1855–1858Google Scholar
  151. Scheidt J vom (1973) Sigmund Freud und das Kokain. Psyche 27: 385–430Google Scholar
  152. Siegel RK (1978) Cocaine hallucinations. Am J Psychiatry 135: 309–314Google Scholar
  153. Smith DE, Wasson DR (1978) Cocaine. J Psychedelic Drugs 10: 351–360CrossRefGoogle Scholar
  154. Spiehler VR, Reed D (1985) Brain Concentrations of Cocaine and Benzoylecgonine in Fatal Case. J Forensic Sci 40 /4: 1003–1011Google Scholar
  155. String DL, Hunt DE, Goldsmith DS (1985) Patterns of cocaine use among methadone clients. Int J Addict 20: 1163–1175Google Scholar
  156. Suarez CA, Arango A, Lester JL (1977) Cocaine - condom ingestion. Surgial treatment. Jama 238: 1391–1392Google Scholar
  157. Suzuki O, Hattori H, Asano M (1984) Nails and hair as useful materials for detection of methamphetamin or amphetamin abuse. Forensic Sci Intern 24: 9–16CrossRefGoogle Scholar
  158. Täschner K-L (1988) Koka und Kokain - Konsum und Wirkungen. Deutscher Ärzteverlag, KölnGoogle Scholar
  159. Täschner K-L (1989) Cocain–Kein “Schnee” von gestern. Dtsch Apoth Z 37: 1955–1959Google Scholar
  160. Täschner K-L, Richtberg W (1982) Kokain-Report. Akademische Verlagsgesellschaft, WiesbadenGoogle Scholar
  161. Täschner K-L, Bort G (1987) Kokainmissbrauch–eine unterschätzte Gefahr ? Suchtgefahren 33: 369–375Google Scholar
  162. Thamm BG (1984) Kokain–Schnee von Morgen. Psychol heute 11: 56–59Google Scholar
  163. Thamm BG (1986) Andenschnee: die lange Linie des Kokains. Sphinx, BaselGoogle Scholar
  164. Toennes SW, Kauert GF (2000) Nachweis und Häufigkeit des kombinierten Konsums von Kokain und Ethanol. Blutalkohol 37 /6: 434–439Google Scholar
  165. Villinger W (1941) Pervitin, Suchtproblem und Suchtbekämpfung. Nervenarzt 14: 405–408Google Scholar
  166. Voigt HP (1982) Zum Thema: Kokain. Sphinx, BaselGoogle Scholar
  167. Weir S (1985) Qat im Yemen. British Museum Publications, DorsetGoogle Scholar
  168. Wetli CV, Wright RK (1969) Death caused by recreational cocaine use. Jama 241: 25192522Google Scholar
  169. Wilkinson P, Dyke C van, Jatlow P et al. (1980) Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27: 386–394CrossRefGoogle Scholar
  170. Witkop B, Foltz CM (1957) Studies on the stereochemistry of ephedrine and yr-ephedrine. J Chem Soc 79: 197–199CrossRefGoogle Scholar
  171. Zapata-Ortiz V, Castro de la Mata R, Barrantes Campos R (1961) Die anticonvulsive Wirkung des Cocains. Arzneimittelforsch 11: 657–662Google Scholar
  172. Zimmermann P (1995) Drogenschmuggel im Körper: Erkenntnisse zu Methoden und zur Diagnostik des Körperschmuggels. Kriminalistik 8–9: 556–559Google Scholar
  173. Zuckermann B, Frank DA, Hingson R et al. (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320: 762–768CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Thomas Geschwinde
    • 1
  1. 1.HanauDeutschland

Personalised recommendations